This “soluble” MICA reduced cell surface expression of NKG2D on tumor infiltrating lymphocytes (TIL), NK cells and γ:δ T cells, ultimately resulting in an impaired responsiveness to NKG2D activation (12). Here, KLRK1 is linked to neoplasm.